|
 |
|
| Home > Chemicals > Life Science Intermediates |
| |
 Life Science Intermediates Market Research Reports |
Top 2011 Top Ten World's Leading Life Science Intermediates Companies
This unique report was provides Life Science industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs.The companies analyzed in the report include: BASF, Cambrex, Clariant, DowPharma, DSM, Evonik, Lanxess, Lonza, Novasep, and Rhodia....
|
 |
|
$12500.00 |
| |
|
|
|
Lanxess: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Lanxess, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 43 pages and 7 tables
|
|
|
$1900.00 |
| |
|
|
|
Cambrex: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategic assessment of Cambrex, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 56 pages and 9 tables
|
|
|
$1900.00 |
| |
|
|
|
Clariant: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategic assessment of Clariant, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 41 pages and 5 tables
|
|
|
$1900.00 |
| |
|
|
|
DowPharma: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of DowPharma, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 53 pages and 5 tables
|
|
|
$1900.00 |
| |
|
|
|
DSM: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of DSM, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 46 pages and 11 tables
|
|
|
$1900.00 |
| |
|
|
|
Evonik: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Evonik, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 45 pages and 9 tables
|
|
|
$1900.00 |
| |
|
|
|
Lonza: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Lonza, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 66 pages and 15 tables
|
|
|
$1900.00 |
| |
|
|
|
Novasep: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Novasep, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 38 pages and 1 table
|
|
|
$1900.00 |
| |
|
|
|
Rhodia: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Rhodia, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 63 pages and 7 tables
|
|
|
$1900.00 |
| |
|
|
|
The 2011 Global Life Science Intermediates Market Dynamics and Trends
This concise report on the life science intermediates market presents:
|
|
|
$1850.00 |
| |
|
|
|
The 2011 Leading Life Science Intermediates Companies Strategic Directions
For each company, the report provides insightful strategic assessments, including:- Specific business, new product development and marketing strategies.
- Strengths and weaknesses....
|
|
|
$1850.00 |
| |
|
|
|
The 2011 Leading Life Science Intermediates Companies Marketing Tactics
For each company, the analysis presents:- Major promotional strategies.
- Distribution approaches....
|
|
|
$1850.00 |
| |
|
|
|
The 2011 Leading Life Science Intermediates Companies Collaborations
For each company, the report presents:- Major joint venture, distribution, OEM and licensing partners, both industrial and academic.
- Terms of collaborative agreements and specific products involved....
|
|
|
$1850.00 |
| |
|
|
|
The 2011 Leading Life Science Intermediates Companies Financial Analyses
For each company the report presents:- Sales and operating profit by division, product line, geographic region and country.
- Five-year sales and profit performance....
|
|
|
$1850.00 |
| |
|
|
|
The 2011 Leading Life Science Intermediates Companies Organizations and Management
For each company, the report presents:- History of the life science intermediates business evolution, important to the understanding of the corporate culture, management mentality and strategies.
- Recent acquisitions, divestitures and significant organizational changes....
|
|
|
$1850.00 |
| |
|
|
|
The 2011 Leading Life Science Intermediates Companies R&D Expenditures and Major Programs
For each company, the report presents:- Estimated R&D budget.
- Research facilities and staff....
|
|
|
$1850.00 |
| |
|
|
|
The 2011 Leading Life Science Intermediates Companies Technological Know-How
For each company, the report presents:- Internally developed and acquired technologies, and related capabilities.
- Proprietary technologies and patent litigations....
|
|
|
$1850.00 |
| |
|
|
|
|